High materiality8/10
Adagene initiated with a Buy at Chardan
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
very_bullish
What happened, with direct paths to the underlying reporting
Chardan Capital initiated Adagene with a Buy rating; target $9; current price $3.27.
Target: $9
Posted price: $3.27
Analyst firm: Chardan Capital
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.